Pfizer and BioNTech Report New Data on Omicron
One month after a 30-µg booster dose of the Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine, neutralizing antibody titers against emerging Omicron...
Source: globenewswire.com
📰 Ivalenter Impfstoff News
Ivalenter Impfstoff News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Ivalenter Impfstoff. Real-time updates on events, politics, business and more.
Pfizer and BioNTech Submit Application to U.S. FDA for
NEW YORK and MAINZ, GERMANY, September 26, 2022 — Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced they have completed a submission...
Submit Application Emergency Use Authorization Adapted Bivalent Vaccine Booster Nasdaq Bntx Biontech Se Covid 19
Source: globenewswire.com